Skip to main content
Premium Trial:

Request an Annual Quote

IP Services Firm Files for Reexamination of Abbott Multiplex PCR Patent

NEW YORK (GenomeWeb News) – Troll Busters, an intellectual property services firm that specializes in challenging the validity or claims of certain patents, today announced that it has filed a brief with the US Patent and Trademark Office for reexamination of a patent covering multiplex PCR-based diagnostics.
The patent at issue, No. 5,582,989, is entitled “Multiplex genomic DNA amplification for deletion detection,” and covers a method for detecting multiple DNA sequences simultaneously. Multiplex, PCR-based genetic tests may fall under the broad-based claims of the patent.
Baylor College of Medicine is listed as the assignee of the patent, which was granted in December 1996. The patent is exclusively licensed to Abbott Laboratories.
The claims in the patent “are overly broad,” Jeff Oster, founder of Troll Busters, told GenomeWeb Daily News. “There is prior art, there’s new prior art that was not considered during the US application, and the US file history had a lot of flaws in it,” he added.
Oster said the USPTO generally takes around three months to decide whether or not it will reexamine the patent.
He said the reexamination brief should be available on the USPTO website next week.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.